-
2
-
-
0037206364
-
Long-term trends in the incidence of and survival with heart failure
-
Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
-
(2002)
N Engl J Med
, vol.347
, pp. 1397-1402
-
-
Levy, D.1
Kenchaiah, S.2
Larson, M.G.3
-
3
-
-
0032741126
-
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort
-
Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955.
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 1948-1955
-
-
Vasan, R.S.1
Larson, M.G.2
Benjamin, E.J.3
-
4
-
-
0037058826
-
Lifetime risk for developing congestive heart failure: The Framingham Heart Study
-
Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068-3072.
-
(2002)
Circulation
, vol.106
, pp. 3068-3072
-
-
Lloyd-Jones, D.M.1
Larson, M.G.2
Leip, E.P.3
-
5
-
-
0030002580
-
The progression from hypertension to congestive heart failure
-
Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
-
(1996)
JAMA
, vol.275
, pp. 1557-1562
-
-
Levy, D.1
Larson, M.G.2
Vasan, R.S.3
-
6
-
-
0029793195
-
The role of hypertension in the pathogenesis of heart failure: A clinical mechanistic overview
-
Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med. 1996;156:1789-1796.
-
(1996)
Arch Intern Med
, vol.156
, pp. 1789-1796
-
-
Vasan, R.S.1
Levy, D.2
-
7
-
-
0030744599
-
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group
-
Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group. JAMA. 1997;278:212-216.
-
(1997)
JAMA
, vol.278
, pp. 212-216
-
-
Kostis, J.B.1
Davis, B.R.2
Cutler, J.3
-
8
-
-
0036681988
-
Obesity and the risk of heart failure
-
Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
-
(2002)
N Engl J Med
, vol.347
, pp. 305-313
-
-
Kenchaiah, S.1
Evans, J.C.2
Levy, D.3
-
9
-
-
0025688110
-
Smoking and hypertension as predictors of cardiovascular risk in population studies
-
Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl. 1990;8:S3-8.
-
(1990)
J Hypertens Suppl
, vol.8
-
-
Kannel, W.B.1
Higgins, M.2
-
10
-
-
0141468244
-
Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169.
-
(2003)
Circulation
, vol.108
, pp. 2154-2169
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
-
11
-
-
0035846616
-
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
(Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America
-
Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation. 2001;104:2996-3007.
-
(2001)
Circulation
, vol.104
, pp. 2996-3007
-
-
Hunt, S.A.1
Baker, D.W.2
Chin, M.H.3
-
12
-
-
3342950243
-
New guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension: From JNC VI to JNC VII
-
Britov AN, Bystrova MM. [New guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension: from JNC VI to JNC VII]. Kardiologiia. 2003;43:93-97.
-
(2003)
Kardiologiia
, vol.43
, pp. 93-97
-
-
Britov, A.N.1
Bystrova, M.M.2
-
13
-
-
0026695294
-
The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
-
Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 248-254
-
-
Packer, M.1
-
14
-
-
0034990519
-
B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure
-
Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail. 2001;7:183-193.
-
(2001)
J Card Fail
, vol.7
, pp. 183-193
-
-
Maisel, A.1
-
15
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
-
(2002)
N Engl J Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
-
16
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators
-
Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
-
17
-
-
0023266532
-
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): The CONSENSUS Trial Study Group
-
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): the CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-1435.
-
(1987)
N Engl J Med
, vol.316
, pp. 1429-1435
-
-
-
18
-
-
0033501328
-
Perindopril for elderly people with chronic heart failure: The PEP-CHF study: The PEP investigators
-
Cleland JG, Tendera M, Adamus J, et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study: the PEP investigators. Eur J Heart Fail. 1999;1:211-217.
-
(1999)
Eur J Heart Fail
, vol.1
, pp. 211-217
-
-
Cleland, J.G.1
Tendera, M.2
Adamus, J.3
-
19
-
-
0026785561
-
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
-
The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
-
(1992)
N Engl J Med
, vol.327
, pp. 685-691
-
-
-
20
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
-
21
-
-
0033534085
-
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group
-
Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group. Circulation. 1999;100:2312-2318.
-
(1999)
Circulation
, vol.100
, pp. 2312-2318
-
-
Packer, M.1
Poole-Wilson, P.A.2
Armstrong, P.W.3
-
22
-
-
0028955321
-
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials
-
Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:1450-1456.
-
(1995)
JAMA
, vol.273
, pp. 1450-1456
-
-
Garg, R.1
Yusuf, S.2
-
23
-
-
0031050642
-
Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
-
Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349:375-380.
-
(1997)
Lancet
, vol.349
, pp. 375-380
-
-
-
24
-
-
10544231452
-
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure: US Carvedilol Heart Failure Study Group
-
Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure: US Carvedilol Heart Failure Study Group. Circulation. 1996;94:2800-2806.
-
(1996)
Circulation
, vol.94
, pp. 2800-2806
-
-
Colucci, W.S.1
Packer, M.2
Bristow, M.R.3
-
25
-
-
0029937949
-
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group
-
Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355.
-
(1996)
N Engl J Med
, vol.334
, pp. 1349-1355
-
-
Packer, M.1
Bristow, M.R.2
Cohn, J.N.3
-
26
-
-
10544251442
-
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial: Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise
-
Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE Trial: Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation. 1996;94:2793-2799.
-
(1996)
Circulation
, vol.94
, pp. 2793-2799
-
-
Packer, M.1
Colucci, W.S.2
Sackner-Bernstein, J.D.3
-
27
-
-
0035195529
-
Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers
-
Lindenfeld J, Robertson AD, Lowes BD, et al. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers. J Am Coll Cardiol. 2001;38:1950-1956.
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 1950-1956
-
-
Lindenfeld, J.1
Robertson, A.D.2
Lowes, B.D.3
-
28
-
-
0033549290
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
-
(1999)
Lancet
, vol.353
, pp. 2001-2007
-
-
-
29
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
30
-
-
0035978801
-
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
-
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
-
(2001)
N Engl J Med
, vol.344
, pp. 1659-1667
-
-
-
31
-
-
3142776467
-
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial
-
Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7-13.
-
(2003)
Lancet
, vol.362
, pp. 7-13
-
-
Poole-Wilson, P.A.1
Swedberg, K.2
Cleland, J.G.3
-
32
-
-
0027135308
-
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group
-
Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993;342:1441-1446.
-
(1993)
Lancet
, vol.342
, pp. 1441-1446
-
-
Waagstein, F.1
Bristow, M.R.2
Swedberg, K.3
-
33
-
-
0030902115
-
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
-
Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
-
34
-
-
0034612118
-
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial: The Losartan Heart Failure Survival Study ELITE II
-
Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial: the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582-1587.
-
(2000)
Lancet
, vol.355
, pp. 1582-1587
-
-
Pitt, B.1
Poole-Wilson, P.A.2
Segal, R.3
-
35
-
-
0037027511
-
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: The Valsartan Heart Failure Trial (Val-HeFT)
-
Latini R, Masson S, Anand I, et al. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2002;106:2454-2458.
-
(2002)
Circulation
, vol.106
, pp. 2454-2458
-
-
Latini, R.1
Masson, S.2
Anand, I.3
-
36
-
-
0037120958
-
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
-
Maggioni AP, Anand I, Gottlieb SO, et al. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2002;40:1414-1421.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1414-1421
-
-
Maggioni, A.P.1
Anand, I.2
Gottlieb, S.O.3
-
37
-
-
0042410539
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme
-
Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759-766.
-
(2003)
Lancet
, vol.362
, pp. 759-766
-
-
Pfeffer, M.A.1
Swedberg, K.2
Granger, C.B.3
-
38
-
-
0041408234
-
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
-
Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781.
-
(2003)
Lancet
, vol.362
, pp. 777-781
-
-
Yusuf, S.1
Pfeffer, M.A.2
Swedberg, K.3
-
39
-
-
0041909380
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial
-
Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772-776.
-
(2003)
Lancet
, vol.362
, pp. 772-776
-
-
Granger, C.B.1
McMurray, J.J.2
Yusuf, S.3
-
40
-
-
0041408235
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial
-
McMurray JJ, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767-771.
-
(2003)
Lancet
, vol.362
, pp. 767-771
-
-
McMurray, J.J.1
Ostergren, J.2
Swedberg, K.3
-
41
-
-
0242490542
-
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
-
Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893-1906.
-
(2003)
N Engl J Med
, vol.349
, pp. 1893-1906
-
-
Pfeffer, M.A.1
McMurray, J.J.2
Velazquez, E.J.3
-
42
-
-
0027297873
-
Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure: The V-HeFT VA Cooperative Studies Group
-
Loeb HS, Johnson G, Henrick A, et al. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure: the V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(6 suppl):VI78-87.
-
(1993)
Circulation
, vol.87
, Issue.6 SUPPL.
-
-
Loeb, H.S.1
Johnson, G.2
Henrick, A.3
-
43
-
-
0036023202
-
African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology
-
Franciosa JA, Taylor AL, Cohn JN, et al. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. J Card Fail. 2002;8:128-135.
-
(2002)
J Card Fail
, vol.8
, pp. 128-135
-
-
Franciosa, J.A.1
Taylor, A.L.2
Cohn, J.N.3
-
44
-
-
0036729830
-
The African-American Heart Failure Trial: Background, rationale and significance
-
Taylor AL, Cohn JN, Worcel M, et al. The African-American Heart Failure Trial: background, rationale and significance. J Natl Med Assoc. 2002;94:762-769.
-
(2002)
J Natl Med Assoc
, vol.94
, pp. 762-769
-
-
Taylor, A.L.1
Cohn, J.N.2
Worcel, M.3
-
45
-
-
0031051347
-
The effect of digoxin on mortality and morbidity in patients with heart failure
-
Garg R, Gorlin R, Smith T, et al. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533.
-
(1997)
N Engl J Med
, vol.336
, pp. 525-533
-
-
Garg, R.1
Gorlin, R.2
Smith, T.3
-
46
-
-
0342378157
-
Patients with mild heart failure worsen during withdrawal from digoxin therapy
-
Adams KF Jr, Gheorghiade M, Uretsky BF, et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997;30:42-48.
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 42-48
-
-
Adams Jr., K.F.1
Gheorghiade, M.2
Uretsky, B.F.3
-
47
-
-
0027216221
-
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study
-
Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study. N Engl J Med. 1993;329:1-7.
-
(1993)
N Engl J Med
, vol.329
, pp. 1-7
-
-
Packer, M.1
Gheorghiade, M.2
Young, J.B.3
-
48
-
-
0037071808
-
Cardiac resynchronization in chronic heart failure
-
Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
-
(2002)
N Engl J Med
, vol.346
, pp. 1845-1853
-
-
Abraham, W.T.1
Fisher, W.G.2
Smith, A.L.3
-
49
-
-
0037638884
-
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial
-
Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-2694.
-
(2003)
JAMA
, vol.289
, pp. 2685-2694
-
-
Young, J.B.1
Abraham, W.T.2
Smith, A.L.3
-
50
-
-
2442479695
-
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
-
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
-
(2004)
N Engl J Med
, vol.350
, pp. 2140-2150
-
-
Bristow, M.R.1
Saxon, L.A.2
Boehmer, J.3
-
51
-
-
0037307437
-
Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker- defibrillators reduce all-cause mortality and hospitalization
-
Salukhe TV, Francis DP, Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization. Int J Cardiol. 2003;87:119-120.
-
(2003)
Int J Cardiol
, vol.87
, pp. 119-120
-
-
Salukhe, T.V.1
Francis, D.P.2
Sutton, R.3
-
52
-
-
0006918490
-
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators
-
Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-1940.
-
(1996)
N Engl J Med
, vol.335
, pp. 1933-1940
-
-
Moss, A.J.1
Hall, W.J.2
Cannom, D.S.3
-
53
-
-
0037149716
-
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
-
Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
-
(2002)
N Engl J Med
, vol.346
, pp. 877-883
-
-
Moss, A.J.1
Zareba, W.2
Hall, W.J.3
-
54
-
-
2442572117
-
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
-
Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
-
(2004)
N Engl J Med
, vol.350
, pp. 2151-2158
-
-
Kadish, A.1
Dyer, A.2
Daubert, J.P.3
-
55
-
-
2642573545
-
-
Grimm W, Alter P, Maisch B. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy: results of MACAS, DEFINITE, and SCD-HeFT. 2004;29:348-352.
-
(2004)
Arrhythmia Risk Stratification with Regard to Prophylactic Implantable Defibrillator Therapy in Patients with Dilated Cardiomyopathy: Results of MACAS, DEFINITE, and SCD-HeFT
, vol.29
, pp. 348-352
-
-
Grimm, W.1
Alter, P.2
Maisch, B.3
-
56
-
-
0031038213
-
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT: European Myocardial Infarct Amiodarone Trial Investigators
-
Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT: European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667-674.
-
(1997)
Lancet
, vol.349
, pp. 667-674
-
-
Julian, D.G.1
Camm, A.J.2
Frangin, G.3
-
57
-
-
0031029373
-
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators
-
Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997;349:675-682.
-
(1997)
Lancet
, vol.349
, pp. 675-682
-
-
Cairns, J.A.1
Connolly, S.J.2
Roberts, R.3
-
58
-
-
0029004921
-
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure
-
Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995;333:77-82.
-
(1995)
N Engl J Med
, vol.333
, pp. 77-82
-
-
Singh, S.N.1
Fletcher, R.D.2
Fisher, S.G.3
-
59
-
-
0027998462
-
Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
-
Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 1994;344:493-498.
-
(1994)
Lancet
, vol.344
, pp. 493-498
-
-
Doval, H.C.1
Nul, D.R.2
Grancelli, H.O.3
-
60
-
-
0037028593
-
A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission
-
Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471-480.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 471-480
-
-
Kasper, E.K.1
Gerstenblith, G.2
Hefter, G.3
-
61
-
-
0036399630
-
Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study
-
Doughty RN, Wright SP, Pearl A, et al. Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J. 2002;23:139-146.
-
(2002)
Eur Heart J
, vol.23
, pp. 139-146
-
-
Doughty, R.N.1
Wright, S.P.2
Pearl, A.3
-
62
-
-
0037005834
-
Randomized trial of an education and support intervention to prevent readmission of patients with heart failure
-
Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83-89.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 83-89
-
-
Krumholz, H.M.1
Amatruda, J.2
Smith, G.L.3
-
63
-
-
0034645546
-
Effectiveness of team-managed home-based primary care: A randomized multicenter trial
-
Hughes SL, Weaver FM, Giobbie-Hurder A, et al. Effectiveness of team-managed home-based primary care: a randomized multicenter trial. JAMA. 2000;284:2877-2885.
-
(2000)
JAMA
, vol.284
, pp. 2877-2885
-
-
Hughes, S.L.1
Weaver, F.M.2
Giobbie-Hurder, A.3
-
64
-
-
0035978763
-
Effect of carvedilol on survival in severe chronic heart failure
-
Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
-
(2001)
N Engl J Med
, vol.344
, pp. 1651-1658
-
-
Packer, M.1
Coats, A.J.2
Fowler, M.B.3
-
65
-
-
0037149716
-
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
-
Multicenter Automatic Defibrillator Implantation Trial II Investigators
-
Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
-
(2002)
N Engl J Med
, vol.346
, pp. 877-883
-
-
Moss, A.J.1
Zareba, W.2
Hall, W.J.3
|